-
21.
公开(公告)号:US20250075529A1
公开(公告)日:2025-03-06
申请号:US18387840
申请日:2023-11-07
Applicant: Zhiyong LUO
Inventor: Zhiyong LUO
IPC: E05B13/00
Abstract: Square shaped push-button type indicator lock with emergency escape function suitable for disabled people, including a front handle and a front stop block installed on the front handle, a window is provided on the front stop block; a rear handle is provided opposite to the front handle; a rear stop block is installed on the rear handle; a rear fixing plate is installed inside the rear stop block, and front position limiting rods are installed inside the front stop block; the rear through member with a rear through rotary groove on its outer side is installed inside the rear handle; a pressure spring is provided inside the rear through member biasing a pressing member; a mounting through hole in which a guide pin is installed is formed on an upper peripheral portion of the pressing member; a push button is disposed at an outer end of the pressing member.
-
公开(公告)号:US20150197545A1
公开(公告)日:2015-07-16
申请号:US14585438
申请日:2014-12-30
Applicant: Claudio D. Schteingart , Frédérique Menzaghi , Guangcheng Jiang , Roberta Vezza Alexander , Javier Sueiras-Diaz , Robert H. Spencer , Derek T. Chalmers , Robert Zhiyong Luo
Inventor: Claudio D. Schteingart , Frédérique Menzaghi , Guangcheng Jiang , Roberta Vezza Alexander , Javier Sueiras-Diaz , Robert H. Spencer , Derek T. Chalmers , Robert Zhiyong Luo
IPC: C07K5/10
CPC classification number: C07K5/1016 , A61K38/00 , A61K38/07 , C07K5/10 , C07K5/1008 , C07K5/101 , C07K7/02
Abstract: The invention relates to synthetic peptide amide ligands of the kappa opioid receptor and particularly to agonists of the kappa opioid receptor that exhibit low P450 CYP inhibition and low penetration into the brain. The synthetic peptide amides of the invention conform to the structure of formula I: Pharmaceutical compositions containing these compounds are useful in the prophylaxis and treatment of pain and inflammation associated with a variety of diseases and conditions. Such treatable pain includes visceral pain, neuropathic pain and hyperalgesia. Inflammation associated with conditions such as IBD and IBS, ocular and otic inflammation, other disorders and conditions such as pruritis, edema, hyponatremia, hypokalemia, ileus, tussis and glaucoma are treatable or preventable with the pharmaceutical compositions of the invention.
-
公开(公告)号:US08906859B2
公开(公告)日:2014-12-09
申请号:US12868790
申请日:2010-08-26
Applicant: Claudio D. Schteingart , Frederique Menzaghi , Guangcheng Jiang , Roberta Vezza Alexander , Javier Sueiras-Diaz , Robert H. Spencer , Derek T. Chalmers , Robert Zhiyong Luo
Inventor: Claudio D. Schteingart , Frederique Menzaghi , Guangcheng Jiang , Roberta Vezza Alexander , Javier Sueiras-Diaz , Robert H. Spencer , Derek T. Chalmers , Robert Zhiyong Luo
CPC classification number: A61K38/07 , A61K38/08 , C07K5/101 , C07K5/1016 , C07K5/1019 , C07K7/02
Abstract: The invention relates to methods of use of synthetic peptide amides that are ligands of the kappa opioid receptor in the treatment and prevention of kappa opioid receptor-associated diseases and conditions; and particularly to uses of these agonists in the prophylaxis, inhibition and treatment of pain, inflammation and pruritis associated with a variety of diseases, disorders and conditions. Inflammatory conditions preventable or treatable by the methods of the invention include diseases and conditions associated with elevated levels of a proinflammatory cytokines, such as TNF-α, IL-β, IL-6, MMP-1 and MMP-3. Such diseases and conditions include cardiovascular inflammation, neurological inflammation, skeletal inflammation, muscular inflammation, gastrointestinal inflammation, ocular inflammation, otic inflammation, inflammation due to insect bites and inflammation due to wound healing; atherosclerosis, ischemia, restenosis and vasculitis; of asthma, Sjogren's syndrome, pulmonary inflammation, chronic airway inflammation and chronic obstructive pulmonary disease (COPD), allergy, psoriasis, psoriatic arthritis, eczema, scleroderma, atopic dermatitis and systemic lupus erythematosus, arthritis, synovitis, osteomyelitis, rheumatoid arthritis, osteoarthritis and ankylosing spondylitis; septicemia and septic shock, diabetes, glucose intolerance, insulin resistance and obesity, colitis, ulcerative colitis, Crohn's disease, IBD and IBS, and the inflammatory diseases and conditions due to tumor proliferation, tumor metastasis or transplantation rejection.
Abstract translation: 本发明涉及使用作为κ阿片样物质受体的配体的合成肽酰胺在治疗和预防κ阿片受体相关疾病和病症中的使用方法; 特别是这些激动剂在预防,抑制和治疗与各种疾病,病症和病症相关的疼痛,炎症和瘙痒症中的用途。 通过本发明的方法可预防或治疗的炎症状态包括与升高的促炎细胞因子如TNF-α,IL-和bgr,IL-6,MMP-1和MMP-3水平相关的疾病和病症。 这些疾病和病症包括心血管炎症,神经炎症,骨骼炎症,肌肉炎症,胃肠道炎症,眼部炎症,耳炎,由于昆虫叮咬引起的炎症和由于伤口愈合引起的炎症; 动脉粥样硬化,局部缺血,再狭窄和血管炎; 哮喘,干燥综合征,肺部炎症,慢性气道炎症和慢性阻塞性肺病(COPD),过敏,牛皮癣,银屑病关节炎,湿疹,硬皮病,特应性皮炎和系统性红斑狼疮,关节炎,滑膜炎,骨髓炎,类风湿性关节炎,骨关节炎和 强直性脊柱炎; 败血病和败血性休克,糖尿病,葡萄糖不耐受,胰岛素抵抗和肥胖,结肠炎,溃疡性结肠炎,克罗恩病,IBD和IBS,以及由于肿瘤增殖,肿瘤转移或移植排斥引起的炎症疾病和病症。
-
公开(公告)号:US08859538B2
公开(公告)日:2014-10-14
申请号:US12868815
申请日:2010-08-26
Applicant: R. Paul Beckett , Richard Foster , Christelle Henault , Janet L. Ralbovsky , Carla M. Gauss , Gary G. Gustafson , Zhiyong Luo , Ann-Marie Campbell , Tatiana E. Shelekhin
Inventor: R. Paul Beckett , Richard Foster , Christelle Henault , Janet L. Ralbovsky , Carla M. Gauss , Gary G. Gustafson , Zhiyong Luo , Ann-Marie Campbell , Tatiana E. Shelekhin
IPC: A61P29/00 , A61P25/04 , A61K31/519 , C07D487/04 , C07D519/00
CPC classification number: C07D487/04 , C07D519/00
Abstract: The present invention provides a method of prophylaxis, treatment or inhibition of a cannabinoid receptor-associated disease, disorder or condition in a mammalian subject, the method comprising administering to the subject a compound having the structure of formula I or a pharmaceutically acceptable salt, acid salt, hydrate or stereoisomer thereof, wherein the cannabinoid receptor-associated disease, disorder or condition is pain or an inflammatory disease, disorder or condition, and wherein formula I is as follows: wherein Rb, Rc, Z, Y and m are defined in the specification.
Abstract translation: 本发明提供了在哺乳动物受试者中预防,治疗或抑制大麻素受体相关疾病,病症或病症的方法,所述方法包括向受试者施用具有结构式I的化合物或其药学上可接受的盐,酸 盐,水合物或立体异构体,其中大麻素受体相关疾病,病症或病症是疼痛或炎性疾病,病症或病症,其中式I如下:其中Rb,Rc,Z,Y和m定义于 规格。
-
公开(公告)号:US08653127B2
公开(公告)日:2014-02-18
申请号:US13126490
申请日:2010-01-14
Applicant: Robert Zhiyong Luo
Inventor: Robert Zhiyong Luo
IPC: A61P29/00 , A61P17/04 , A61K31/437 , C07D403/04 , C07D487/04 , C07D491/04
CPC classification number: A61K31/437 , C07D231/56 , C07D401/04 , C07D403/04 , C07D413/12 , C07D471/04 , C07D487/04 , C07D491/04 , C07D491/10
Abstract: The present invention provides substituted pyrazolo-heterocycles having the general structure of formula I The structures of rings A and B and substituents Ra, Rb and Rc are described in the specification. Also provided are pharmaceutically acceptable salts, acid salts, hydrates, solvates and stereoisomers of the compounds of formula I. The compounds are useful as modulators of cannabinoid receptors and for the prophylaxis, treatment and inhibition of cannabinoid receptor-associated diseases and conditions, such as pain, inflammation and pruritis.
Abstract translation: 本发明提供具有通式I的通式结构的取代的吡唑并 - 杂环环A和B以及取代基R a,R b和R c的结构在说明书中描述。 还提供了式I化合物的药学上可接受的盐,酸式盐,水合物,溶剂合物和立体异构体。该化合物可用作大麻素受体的调节剂和用于预防,治疗和抑制大麻素受体相关疾病和病症,例如 疼痛,炎症和瘙痒。
-
公开(公告)号:US08536131B2
公开(公告)日:2013-09-17
申请号:US12913363
申请日:2010-10-27
Applicant: Claudio D. Schteingart , Frédérique Menzaghi , Guangcheng Jiang , Roberta Vezza Alexander , Javier Sueiras-Diaz , Robert H. Spencer , Derek T. Chalmers , Zhiyong Luo
Inventor: Claudio D. Schteingart , Frédérique Menzaghi , Guangcheng Jiang , Roberta Vezza Alexander , Javier Sueiras-Diaz , Robert H. Spencer , Derek T. Chalmers , Zhiyong Luo
IPC: A61K38/07
CPC classification number: C07K5/1016 , A61K38/00 , C07K5/1005 , C07K5/1008 , C07K5/1024 , C07K7/06
Abstract: The invention relates to synthetic peptide amide ligands of the kappa opioid receptor and particularly to agonists of the kappa opioid receptor that exhibit low P450 CYP inhibition and low penetration into the brain. The synthetic peptide amides of the invention conform to the structure: The compounds are useful in the prophylaxis and treatment of pain and inflammation associated with a variety of diseases and conditions.
Abstract translation: 本发明涉及κ阿片样物质受体的合成肽酰胺配体,特别是涉及低P450 CYP抑制和低渗透入脑的κ阿片受体激动剂。 本发明的合成肽酰胺符合以下结构:该化合物可用于预防和治疗与各种疾病和病症相关的疼痛和炎症。
-
公开(公告)号:US08236766B2
公开(公告)日:2012-08-07
申请号:US12480059
申请日:2009-06-08
Applicant: Claudio D. Schteingart , Frederique Menzaghi , Guangcheng Jiang , Roberta Vezza Alexander , Javier Sueiras-Diaz , Robert H. Spencer , Derek T. Chalmers , Zhiyong Luo
Inventor: Claudio D. Schteingart , Frederique Menzaghi , Guangcheng Jiang , Roberta Vezza Alexander , Javier Sueiras-Diaz , Robert H. Spencer , Derek T. Chalmers , Zhiyong Luo
IPC: A61K38/07
CPC classification number: C07K5/1016 , C07K7/02
Abstract: The invention relates to synthetic peptide amides that are ligands of the kappa opioid receptor and particularly to agonists of the kappa opioid receptor that exhibit low P450 CYP inhibition and low penetration into the brain. The synthetic peptide amides of the invention conform to the structure: wherein Xaa is a D-amino acid and G is selected from the following three groups: The compounds are useful in the prophylaxis and treatment of pain, pruritus and inflammation associated with a variety of diseases and conditions.
Abstract translation: 本发明涉及作为κ阿片受体的配体的合成肽酰胺,特别是涉及低P450 CYP抑制和低渗透入脑的κ阿片样物质受体的激动剂。 本发明的合成肽酰胺符合以下结构:其中Xaa是D-氨基酸,G选自以下三组:所述化合物可用于预防和治疗与各种各样的相关的疼痛,瘙痒和炎症 疾病和病症。
-
公开(公告)号:US20110257105A1
公开(公告)日:2011-10-20
申请号:US12913363
申请日:2010-10-27
Applicant: Claudio D. Schteingart , Frédérique Menzaghi , Guangcheng Jiang , Roberta Vezza Alexander , Javier Sueiras-Diaz , Robert H. Spencer , Derek T. Chalmers , Zhiyong Luo
Inventor: Claudio D. Schteingart , Frédérique Menzaghi , Guangcheng Jiang , Roberta Vezza Alexander , Javier Sueiras-Diaz , Robert H. Spencer , Derek T. Chalmers , Zhiyong Luo
IPC: A61K38/08 , A61K38/07 , C07K7/06 , A61P3/10 , A61P27/02 , A61P13/12 , A61P25/04 , A61P35/00 , A61P29/00 , A61P19/02 , A61P1/00 , C07K5/10 , A61P31/12
CPC classification number: C07K5/1016 , A61K38/00 , C07K5/1005 , C07K5/1008 , C07K5/1024 , C07K7/06
Abstract: The invention relates to synthetic peptide amide ligands of the kappa opioid receptor and particularly to agonists of the kappa opioid receptor that exhibit low P450 CYP inhibition and low penetration into the brain. The synthetic peptide amides of the invention conform to the structure: The compounds are useful in the prophylaxis and treatment of pain and inflammation associated with a variety of diseases and conditions.
Abstract translation: 本发明涉及κ阿片样物质受体的合成肽酰胺配体,特别是涉及低P450 CYP抑制和低渗透入脑的κ阿片受体激动剂。 本发明的合成肽酰胺符合以下结构:该化合物可用于预防和治疗与各种疾病和病症相关的疼痛和炎症。
-
公开(公告)号:US20110212882A1
公开(公告)日:2011-09-01
申请号:US12868790
申请日:2010-08-26
Applicant: Claudio D. Schteingart , Frédérique Menzaghi , Guangcheng Jiang , Roberta Vezza Alexander , Javier Sueiras-Diaz , Robert H. Spencer , Derek T. Chalmers , Robert Zhiyong Luo
Inventor: Claudio D. Schteingart , Frédérique Menzaghi , Guangcheng Jiang , Roberta Vezza Alexander , Javier Sueiras-Diaz , Robert H. Spencer , Derek T. Chalmers , Robert Zhiyong Luo
IPC: A61K38/07 , A61P17/00 , A61P19/00 , A61P19/02 , A61P25/00 , A61P3/04 , A61P3/10 , A61P35/00 , A61P25/04
CPC classification number: A61K38/07 , A61K38/08 , C07K5/101 , C07K5/1016 , C07K5/1019 , C07K7/02
Abstract: The invention relates to methods of use of synthetic peptide amides that are ligands of the kappa opioid receptor in the treatment and prevention of kappa opioid receptor-associated diseases and conditions; and particularly to uses of these agonists in the prophylaxis, inhibition and treatment of pain, inflammation and pruritis associated with a variety of diseases, disorders and conditions. Inflammatory conditions preventable or treatable by the methods of the invention include diseases and conditions associated with elevated levels of a proinflammatory cytokines, such as TNF-α, IL-β, IL-6, MMP-1 and MMP-3. Such diseases and conditions include cardiovascular inflammation, neurological inflammation, skeletal inflammation, muscular inflammation, gastrointestinal inflammation, ocular inflammation, otic inflammation, inflammation due to insect bites and inflammation due to wound healing; atherosclerosis, ischemia, restenosis and vasculitis; of asthma, Sjogren's syndrome, pulmonary inflammation, chronic airway inflammation and chronic obstructive pulmonary disease (COPD), allergy, psoriasis, psoriatic arthritis, eczema, scleroderma, atopic dermatitis and systemic lupus erythematosus, arthritis, synovitis, osteomyelitis, rheumatoid arthritis, osteoarthritis and ankylosing spondylitis; septicemia and septic shock, diabetes, glucose intolerance, insulin resistance and obesity, colitis, ulcerative colitis, Crohn's disease, IBD and IBS, and the inflammatory diseases and conditions due to tumor proliferation, tumor metastasis or transplantation rejection.
Abstract translation: 本发明涉及使用作为κ阿片样物质受体的配体的合成肽酰胺在治疗和预防κ阿片受体相关疾病和病症中的使用方法; 特别是这些激动剂在预防,抑制和治疗与各种疾病,病症和病症相关的疼痛,炎症和瘙痒症中的用途。 通过本发明的方法可预防或治疗的炎症状态包括与升高的促炎细胞因子如TNF-α,IL-和bgr,IL-6,MMP-1和MMP-3水平相关的疾病和病症。 这些疾病和病症包括心血管炎症,神经炎症,骨骼炎症,肌肉炎症,胃肠道炎症,眼部炎症,耳炎,由于昆虫叮咬引起的炎症和由于伤口愈合引起的炎症; 动脉粥样硬化,局部缺血,再狭窄和血管炎; 哮喘,干燥综合征,肺部炎症,慢性气道炎症和慢性阻塞性肺病(COPD),过敏,牛皮癣,银屑病关节炎,湿疹,硬皮病,特应性皮炎和系统性红斑狼疮,关节炎,滑膜炎,骨髓炎,类风湿性关节炎,骨关节炎和 强直性脊柱炎; 败血病和败血性休克,糖尿病,葡萄糖不耐受,胰岛素抵抗和肥胖,结肠炎,溃疡性结肠炎,克罗恩病,IBD和IBS,以及由于肿瘤增殖,肿瘤转移或移植排斥引起的炎症疾病和病症。
-
公开(公告)号:US20110034443A1
公开(公告)日:2011-02-10
申请号:US12868815
申请日:2010-08-26
Applicant: R. Paul Beckett , Richard Foster , Christelle Henault , Janet L. Ralbovsky , Carla M. Gauss , Gary G. Gustafson , Robert Zhiyong Luo , Ann-Marie Campbell , Tatiana E. Shelekhin , Mary-Margaret E. Zablocki
Inventor: R. Paul Beckett , Richard Foster , Christelle Henault , Janet L. Ralbovsky , Carla M. Gauss , Gary G. Gustafson , Robert Zhiyong Luo , Ann-Marie Campbell , Tatiana E. Shelekhin , Mary-Margaret E. Zablocki
IPC: A61K31/551 , A61K31/4985 , A61K31/5377 , A61P29/00 , A61P37/08 , A61P17/06 , A61P17/00 , A61P37/02 , A61P19/02 , A61P19/08 , A61P31/00 , A61P3/10 , A61P3/04 , A61P5/50 , A61P1/00 , A61P25/06
CPC classification number: C07D487/04 , C07D519/00
Abstract: The present invention provides methods of prevention and treatment of cannabinoid receptor-associated diseases and conditions, wherein the method includes administering a substituted imidazoheterocyclic compounds having the structure of formula I or a pharmaceutically acceptable salt, acid salt, hydrate, solvate or stereoisomer of a compound having the structure of formula I. The cannabinoid receptor-associated diseases and conditions preventable or treatable by the methods of the present invention include pain, inflammation and pruritis.
Abstract translation: 本发明提供了预防和治疗大麻素受体相关疾病和病症的方法,其中所述方法包括给予具有式I结构的取代的咪唑并杂环化合物或化合物的药学上可接受的盐,酸盐,水合物,溶剂合物或立体异构体 具有式I的结构。通过本发明的方法可预防或可治疗的大麻素受体相关疾病和病症包括疼痛,炎症和瘙痒。
-
-
-
-
-
-
-
-
-